1. PAD Treater Survey, 2009. ©The Angiogenesis Foundation.

2. Nikol S, Baumgartner I, Van Belle E, et al. Mol Ther 2008;16:972-978.

3. Sibbald RG, Torrance G, Hux M, Attard C, Milkovich N. Cost effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers. Ostomy Wound Manage 2003;49(11):76-84.

4. Sheikh AY, Rollins MD, Hopf HW, Hunt TK. Hyperoxia improves microvascular perfusion in a murine wound model. Wound Repair Regen 2005;13:303-308.

5. Venturi ML, Attinger CE, Mesbahi AN, Hess CL, Graw KS. Mechanisms and clinical applications of the vacuum-assisted closure (VAC) device: a review. Am J Clin Dermatol 2005;6:185-194.

6. Kusano KF, Allendoefer KL, Munger W, et al. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler Thromb Vasc Biol 2004;24:2102-2107.

7. Li M, Nishimura H, Kusano KF, et al. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 2005;112:93-102.

8. Kirchmair R, Walter DH, Li M, et al. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation 2005;111:2662-2670.